Evidence map›Paper›PMID 39874013›Full record

Observational studyAsian Pacific journal of cancer prevention : APJCP2025

8-OHdG and Nrf2 Protein are Expressed Consistently in Various T Stages of Invasive Breast Carcinoma.

Fira Soraya, Willy Sandhika, Priangga Adi Wiratama

Abstract readObservational Study
In one paragraph

Observational study in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fira SorayaDepartment of Anatomic Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.ORCID 0000-0003-3660-8467
Willy SandhikaDepartment of Anatomic Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.ORCID 0000-0002-8499-1600
Priangga Adi WiratamaDepartment of Anatomic Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.ORCID 0000-0002-2574-1804

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOxidative stress prompts breast cancer cells to adapt by raising the lethal threshold and enhancing the antioxidant mechanism, thereby enabling survival and continuous proliferation that facilitates tumor progression. Nrf2 and 8-OHdG are indicative of oxidative stress activity and impact the progression of breast cancer. We aimed to analyze the expression of Nrf2 and 8-OHdG in various T stages of breast cancer in our hospital.

methodsThis observational study employed a cross-sectional design and included patients with invasive breast carcinoma of no special type diagnosis from histopathology examination who underwent modified radical mastectomy without neoadjuvant chemotherapy at Dr. Soetomo General Academic Hospital between January 2019 and December 2022. Medical records and paraffin blocks that met these criteria were obtained. 8-OHdG and Nrf2 were assessed using immunohistochemistry.

resultThere was no significant difference and correlation between 8-OHdG (p=0.578) and Nrf2 (p=0.694) expression with various T stages of IBC-NST and no significant correlation between 8-OHdG/Nrf2 expression and T stage (p=0.242 and 0.625 respectively).

conclusionConsistent expression of 8-OHdG and Nrf2 in various T stages of breast cancer represents a continuation of the oxidative stress process in breast cancer that is not influenced by the tumor size. The existence of consistent oxidative stress at all tumor sizes (T stage) stimulates breast cancer cells to continue proliferating.

Indexed as

8-Hydroxy-2'-DeoxyguanosineBiomarkers, TumorBreast NeoplasmsNF-E2-Related Factor 2AdultAgedCross-Sectional StudiesFemaleFollow-Up StudiesHumansMiddle AgedNeoplasm InvasivenessNeoplasm StagingOxidative StressPrognosis8-Hydroxy-2'-DeoxyguanosineBiomarkers, TumorNFE2L2 protein, humanNF-E2-Related Factor 28-OHdGbreast cancerinvasive breast carcinoma of no special typeNrf2

Identifiers

PMID39874013
PMCPMC12082425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.